Hosted on MSN1mon
What’s next for hot biotech stock Viking Therapeutics? Here’s how the company can scale up.
Analysts came away from a meeting with Viking’s management with an update on the program that included their thinking on how they would scale up ... while the SPDR S&P Biotech ETF has gained ...
Nature17d
FDA balks at Myozyme scale-up
The situation highlights “the difficulty a competitor would have coming into the market with a biosimilar,” says senior biotech analyst ... FDA's approval for scale-up projects.